Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival
Year: 2018
Type: conference-abstract
Source: Blood
Authors: Marlijn Hoeks, Tim Bagguley, Rian Roelofs, Louise De Swart, David Bowen, Argiris Symeonidis, Corine van Marrewijk, Eva Hellström-Lindberg, Aurelia Tatic, Saskia Langemeijer, Dominic J. Culligan, Marian Macheta, Hege Garelius, Michail Spanoudakis, Sally Killick, Panagiotis Panagiotidis, Oana Stanca Ciocan, Juliet Mills, Bryson Pottinger, Sam Ackroyd, Claire Hall, Jackie Droste, Alexandra Smith, Dorine W. Swinkels, Theo M de Witte
Institutions: Radboud University Medical Center, University of York, Radboud University Nijmegen, Leeds Teaching Hospitals NHS Trust, University of Patras, Karolinska University Hospital, Karolinska Institutet, Institutul Clinic Fundeni, Aberdeen Royal Infirmary, Blackpool Victoria Hospital, Sahlgrenska University Hospital, Airedale NHS Foundation Trust, Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Laiko General Hospital of Athens, Worcestershire Acute Hospitals NHS Trust, University of Birmingham, Royal Cornwall Hospital, Bradford Royal Infirmary, Harrogate District Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2910031998